Ameriprise
CVS icon

Ameriprise’s CVS Health CVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$542M Buy
7,855,845
+385,806
+5% +$26.6M 0.13% 164
2025
Q1
$506M Buy
7,470,039
+148,546
+2% +$10.1M 0.14% 163
2024
Q4
$329M Buy
7,321,493
+639,325
+10% +$28.7M 0.08% 238
2024
Q3
$420M Sell
6,682,168
-65,525
-1% -$4.12M 0.11% 205
2024
Q2
$399M Buy
6,747,693
+3,214,927
+91% +$190M 0.11% 200
2024
Q1
$282M Sell
3,532,766
-1,208,995
-25% -$96.7M 0.08% 265
2023
Q4
$376M Sell
4,741,761
-1,561,438
-25% -$124M 0.11% 196
2023
Q3
$441M Sell
6,303,199
-2,474,949
-28% -$173M 0.14% 157
2023
Q2
$608M Buy
8,778,148
+128,445
+1% +$8.9M 0.19% 113
2023
Q1
$640M Sell
8,649,703
-2,827,356
-25% -$209M 0.21% 114
2022
Q4
$1.07B Sell
11,477,059
-3,698,054
-24% -$345M 0.37% 57
2022
Q3
$1.45B Sell
15,175,113
-509,974
-3% -$48.9M 0.54% 28
2022
Q2
$1.45B Buy
15,685,087
+1,262,093
+9% +$116M 0.5% 32
2022
Q1
$1.45B Buy
14,422,994
+897,241
+7% +$90M 0.43% 40
2021
Q4
$1.37B Buy
13,525,753
+2,963,269
+28% +$301M 0.38% 47
2021
Q3
$896M Buy
10,562,484
+1,977,119
+23% +$168M 0.29% 67
2021
Q2
$721M Buy
8,585,365
+485,427
+6% +$40.8M 0.22% 94
2021
Q1
$610M Buy
8,099,938
+301,497
+4% +$22.7M 0.2% 109
2020
Q4
$533M Buy
7,798,441
+3,566,284
+84% +$244M 0.19% 111
2020
Q3
$245M Sell
4,232,157
-62,471
-1% -$3.62M 0.1% 219
2020
Q2
$278M Buy
4,294,628
+846,516
+25% +$54.9M 0.12% 185
2020
Q1
$205M Buy
3,448,112
+159,033
+5% +$9.48M 0.11% 199
2019
Q4
$245M Buy
3,289,079
+1,072,122
+48% +$79.9M 0.1% 205
2019
Q3
$140M Buy
2,216,957
+233,704
+12% +$14.7M 0.06% 300
2019
Q2
$108M Sell
1,983,253
-1,429,097
-42% -$77.9M 0.05% 401
2019
Q1
$184M Sell
3,412,350
-2,316,786
-40% -$125M 0.08% 249
2018
Q4
$375M Buy
5,729,136
+1,187,965
+26% +$77.8M 0.19% 108
2018
Q3
$383M Buy
4,541,171
+1,965,071
+76% +$166M 0.13% 176
2018
Q2
$166M Sell
2,576,100
-3,793,854
-60% -$244M 0.07% 270
2018
Q1
$396M Sell
6,369,954
-4,187,393
-40% -$260M 0.18% 125
2017
Q4
$765M Buy
10,557,347
+2,579,977
+32% +$187M 0.35% 58
2017
Q3
$649M Buy
7,977,370
+1,849,593
+30% +$150M 0.31% 69
2017
Q2
$493M Sell
6,127,777
-1,873,867
-23% -$151M 0.25% 91
2017
Q1
$628M Sell
8,001,644
-2,025,267
-20% -$159M 0.33% 63
2016
Q4
$791M Sell
10,026,911
-3,781,327
-27% -$298M 0.43% 41
2016
Q3
$1.23B Sell
13,808,238
-1,268,736
-8% -$113M 0.69% 23
2016
Q2
$1.44B Sell
15,076,974
-2,456,170
-14% -$235M 0.85% 17
2016
Q1
$1.82B Sell
17,533,144
-2,210,310
-11% -$229M 1.09% 10
2015
Q4
$1.93B Sell
19,743,454
-732,701
-4% -$71.6M 1.13% 7
2015
Q3
$1.98B Buy
20,476,155
+1,015,803
+5% +$98M 1.22% 6
2015
Q2
$2.04B Buy
19,460,352
+4,907,205
+34% +$515M 1.16% 4
2015
Q1
$1.5B Buy
14,553,147
+984,415
+7% +$102M 0.86% 9
2014
Q4
$1.31B Buy
13,568,732
+321,851
+2% +$31M 0.76% 16
2014
Q3
$1.05B Buy
13,246,881
+1,130,983
+9% +$90M 0.63% 22
2014
Q2
$913M Buy
12,115,898
+82,167
+0.7% +$6.19M 0.54% 24
2014
Q1
$901M Buy
12,033,731
+2,081,617
+21% +$156M 0.54% 24
2013
Q4
$712M Buy
9,952,114
+535,481
+6% +$38.3M 0.43% 40
2013
Q3
$534M Buy
9,416,633
+1,214,560
+15% +$68.9M 0.35% 53
2013
Q2
$469M Buy
+8,202,073
New +$469M 0.32% 58